PACS Group (NYSE:PACS) Director Mark Hancock Sells 20,338 Shares of Stock

PACS Group, Inc. (NYSE:PACSGet Free Report) Director Mark Hancock sold 20,338 shares of the company’s stock in a transaction on Wednesday, July 8th. The stock was sold at an average price of $45.07, for a total transaction of $916,633.66. Following the transaction, the director owned 53,925,478 shares in the company, valued at approximately $2,430,421,293.46. The trade was a 0.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Hancock also recently made the following trade(s):

  • On Thursday, July 9th, Mark Hancock sold 4,966 shares of PACS Group stock. The shares were sold at an average price of $45.06, for a total transaction of $223,767.96.
  • On Monday, July 6th, Mark Hancock sold 142,163 shares of PACS Group stock. The stock was sold at an average price of $45.33, for a total transaction of $6,444,248.79.
  • On Thursday, July 2nd, Mark Hancock sold 12,825 shares of PACS Group stock. The stock was sold at an average price of $45.01, for a total transaction of $577,253.25.
  • On Wednesday, July 1st, Mark Hancock sold 6,080 shares of PACS Group stock. The shares were sold at an average price of $45.02, for a total transaction of $273,721.60.
  • On Friday, June 26th, Mark Hancock sold 61,931 shares of PACS Group stock. The stock was sold at an average price of $40.50, for a total value of $2,508,205.50.
  • On Thursday, June 25th, Mark Hancock sold 138,069 shares of PACS Group stock. The stock was sold at an average price of $40.33, for a total value of $5,568,322.77.
  • On Wednesday, June 17th, Mark Hancock sold 63,680 shares of PACS Group stock. The stock was sold at an average price of $35.31, for a total value of $2,248,540.80.
  • On Tuesday, June 16th, Mark Hancock sold 83,066 shares of PACS Group stock. The shares were sold at an average price of $35.90, for a total value of $2,982,069.40.
  • On Monday, June 15th, Mark Hancock sold 153,254 shares of PACS Group stock. The shares were sold at an average price of $36.34, for a total value of $5,569,250.36.

PACS Group Stock Down 1.3%

PACS Group stock traded down $0.58 during trading on Friday, hitting $43.24. 687,897 shares of the company were exchanged, compared to its average volume of 926,472. The business’s 50 day moving average is $38.13 and its 200 day moving average is $36.94. PACS Group, Inc. has a 52 week low of $7.50 and a 52 week high of $45.89. The company has a market capitalization of $6.84 billion, a P/E ratio of 27.72, a PEG ratio of 1.31 and a beta of -0.08. The company has a current ratio of 0.99, a quick ratio of 0.99 and a debt-to-equity ratio of 0.27.

PACS Group (NYSE:PACSGet Free Report) last released its quarterly earnings results on Monday, May 11th. The company reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.42 by $0.08. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.36 billion. PACS Group had a return on equity of 26.47% and a net margin of 4.49%. Analysts predict that PACS Group, Inc. will post 2.23 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts recently commented on PACS shares. Oppenheimer lifted their price target on shares of PACS Group from $42.00 to $48.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Weiss Ratings raised PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research report on Wednesday. Truist Financial increased their price target on PACS Group from $50.00 to $52.00 and gave the stock a “buy” rating in a research note on Monday, May 18th. Zacks Research lowered PACS Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 14th. Finally, UBS Group boosted their price objective on PACS Group from $50.00 to $57.00 and gave the company a “buy” rating in a research note on Wednesday. Five investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $50.60.

Check Out Our Latest Analysis on PACS

Institutional Investors Weigh In On PACS Group

A number of institutional investors have recently made changes to their positions in PACS. Hollencrest Capital Management purchased a new stake in PACS Group during the 4th quarter valued at about $27,000. Financial Management Professionals Inc. lifted its position in shares of PACS Group by 54.9% in the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after purchasing an additional 235 shares during the period. Quarry LP grew its holdings in shares of PACS Group by 79.5% during the 3rd quarter. Quarry LP now owns 2,388 shares of the company’s stock worth $33,000 after acquiring an additional 1,058 shares during the period. Larson Financial Group LLC increased its stake in shares of PACS Group by 127.0% in the 4th quarter. Larson Financial Group LLC now owns 1,094 shares of the company’s stock worth $42,000 after acquiring an additional 612 shares in the last quarter. Finally, KBC Group NV purchased a new position in PACS Group during the first quarter valued at $42,000.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Read More

Insider Buying and Selling by Quarter for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.